Prices delayed by at least 15 minutes | Print
Biotech Growth Trust (The) PLC
ORD 25POpen
1,378.00p
Previous close
1,396.00p
Trade high
1,400.84p
Estimated NAV
1,482.74
Year high
1,786.00p
Year low
1,120.00p
Premium / Discount
-5.85%
Market capitalisation
£250.38 mn
Volume
5,441
Dividend yield
–
Ongoing charge
1.1%
ISIN
GB0000385517
Share price
Net asset value (NAV)
| Estimated NAV | 1,482.74 |
|---|---|
| Latest actual NAV | 1,518.72 |
| Latest actual NAV date | 13 November 2026 |
| 12m average premium/discount | -7.83% |
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Vertex Pharmaceuticals Inc | 3.48 |
| Arcutis Biotherapeutics Inc Ordinary Shares | 3.39 |
| Travere Therapeutics Inc Ordinary Shares | 3.03 |
| Biogen Inc | 2.88 |
| Palvella Therapeutics Inc | 2.81 |
| uniQure NV | 2.77 |
| Praxis Precision Medicines Inc Ordinary Shares | 2.46 |
| Rhythm Pharmaceuticals Inc | 2.39 |
| Edgewise Therapeutics Inc | 2.35 |
| Nektar Therapeutics | 2.14 |
Investment objective
The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Morningstar ratingTM
Morningstar sustainability ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 17/11/2026 | 12:22:35 | 1374 | 2 | 29.87 |
| 17/11/2026 | 11:32:32 | 1363.2001 | 300 | 4,089.60 |
| 17/11/2026 | 11:11:53 | 1364.869 | 28 | 382.16 |
| 17/11/2026 | 10:06:00 | 1359.37 | 542 | 7,367.79 |
| 17/11/2026 | 10:47:59 | 1374.1163 | 550 | 7,557.64 |